SecSonar.com

BioRestorative Therapies, Inc. (BRTX)

BioRestorative Therapies, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

BioRestorative Therapies, Inc. (BRTX) is a Biotechnology company based in US with a market capitalization of $4.6M. Revenue declined 10.3% year-over-year and free cash flow was negative at -$10.9M. This page tracks BRTX's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 11 employees · IPO Dec 5, 2012

Valuation

Valuation & price

$0.19 · as of May 17, 2026 · -89.6% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

12.88

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$1.84$1.00$0.17Jul 25Dec 25Jul 26Jul 7, 25$1.52Jul 9, 25$1.62Jul 11, 25$1.62Jul 15, 25$1.54Jul 17, 25$1.59Jul 21, 25$1.59Jul 23, 25$1.70Jul 25, 25$1.62Jul 29, 25$1.53Jul 31, 25$1.47Aug 4, 25$1.48Aug 6, 25$1.46Aug 11, 25$1.41Aug 13, 25$1.50Aug 15, 25$1.52Aug 19, 25$1.51Aug 21, 25$1.51Aug 25, 25$1.51Aug 27, 25$1.56Aug 29, 25$1.84Sep 3, 25$1.73Sep 5, 25$1.60Sep 9, 25$1.57Sep 11, 25$1.60Sep 16, 25$1.48Sep 18, 25$1.45Sep 22, 25$1.48Sep 24, 25$1.45Sep 26, 25$1.43Sep 30, 25$1.45Oct 2, 25$1.43Oct 6, 25$1.53Oct 8, 25$1.66Oct 10, 25$1.62Oct 14, 25$1.61Oct 16, 25$1.58Oct 21, 25$1.59Oct 23, 25$1.58Oct 27, 25$1.59Oct 29, 25$1.56Oct 31, 25$1.54Nov 4, 25$1.46Nov 6, 25$1.40Nov 10, 25$1.38Nov 12, 25$1.38Nov 14, 25$1.33Nov 18, 25$1.24Nov 20, 25$1.11Nov 25, 25$1.11Nov 28, 25$1.08Dec 2, 25$1.04Dec 4, 25$1.11Dec 8, 25$1.08Dec 10, 25$1.10Dec 12, 25$1.11Dec 16, 25$1.08Dec 18, 25$1.18Dec 22, 25$1.16Dec 24, 25$1.19Dec 29, 25$1.10Jan 2, 26$1.22Jan 6, 26$1.17Jan 8, 26$1.20Jan 12, 26$1.18Jan 14, 26$1.18Jan 16, 26$1.15Jan 21, 26$1.15Jan 23, 26$1.14Jan 27, 26$1.10Jan 29, 26$1.14Feb 2, 26$1.15Feb 4, 26$1.03Feb 9, 26$1.05Feb 11, 26$0.41Feb 13, 26$0.28Feb 18, 26$0.27Feb 20, 26$0.22Feb 24, 26$0.27Feb 26, 26$0.23Mar 2, 26$0.21Mar 4, 26$0.22Mar 6, 26$0.21Mar 10, 26$0.28Mar 12, 26$0.31Mar 17, 26$0.25Mar 19, 26$0.26Mar 23, 26$0.33Mar 25, 26$0.31Mar 27, 26$0.30Mar 31, 26$0.27Apr 2, 26$0.28Apr 7, 26$0.25Apr 9, 26$0.24Apr 13, 26$0.26Apr 15, 26$0.26Apr 17, 26$0.26Apr 22, 26$0.23Apr 24, 26$0.23Apr 28, 26$0.22Apr 30, 26$0.23May 4, 26$0.24May 6, 26$0.24May 8, 26$0.21May 12, 26$0.20May 14, 26$0.19May 18, 26$0.19May 20, 26$0.17May 22, 26$0.21May 28, 26$0.48Jun 1, 26$0.41Jun 3, 26$0.34Jun 5, 26$0.41Jun 9, 26$0.39Jun 11, 26$0.38Jun 15, 26$0.39Jun 17, 26$0.40Jun 22, 26$0.41Jun 24, 26$0.40Jun 26, 26$0.37Jul 2, 26$0.40
$0.1752-week range$1.84
Loading valuation history…

Fundamentals

Key fundamentals

$4.6M

Market cap

-10.3%

Revenue growth (YoY)

93.4%

Gross margin

-$10.9M

Free cash flow (USD)

-$3M

Net debt

Net cash position

15.8%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$36.4KFY 2017$81.0KFY 2018$111.0KFY 2019$130.0KFY 2020$77.0KFY 2021$46.0KFY 2022$119.8KFY 2023$145.8KFY 2024$401.0KFY 2025$359.7K
$36.4K$359.7K

Free cash flow by year

2016 → 2025

FY 2016$-5.2MFY 2017$-3.9MFY 2018$-5.1MFY 2019$-7.0MFY 2020$-2.0MFY 2021$-3.4MFY 2022$-6.4MFY 2023$-6.6MFY 2024$-8.3MFY 2025$-10.9M
-$5.2M-$10.9M

Gross margin by year

2021 → 2025

FY 2021100.0%FY 2022100.0%FY 2023100.0%FY 202493.0%FY 202593.4%
100.0%93.4%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last reported: May 14, 2026 (EPS $-0.19)

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventRevolving Credit AgreementJun 12, 2026Filing
  • 8-K eventExecutive Employment AgreementJun 12, 2026Filing
  • 8-K eventExecutive Employment AgreementMay 29, 2026Filing
  • Quarterly report10-Q FiledMay 14, 2026Filing
  • 8-K eventExecutive Bonuses ApprovedMay 1, 2026Filing
  • 8-K eventCorporate Presentation UpdateApr 23, 2026Filing

Questions

Frequently asked questions

What is BioRestorative Therapies, Inc.'s market cap?

BioRestorative Therapies, Inc. (BRTX) has a market capitalization of $4.6M.

What is BRTX's P/E ratio?

A meaningful P/E ratio is not available for BRTX — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is BRTX's price-to-book (P/B) ratio?

BRTX trades at 12.88 times book value per share.

When did BioRestorative Therapies, Inc. last report earnings?

BRTX last reported earnings on May 14, 2026; the next date is not yet scheduled.

Are insiders buying BRTX stock?

SEC Form 4 filings show no open-market insider buys at BioRestorative Therapies, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

MTNB

Matinas BioPharma Holdings, Inc.

$4.5M

HCWB

HCW Biologics Inc.

$4.3M

ADXN

Addex Therapeutics Ltd

$5M

CLGN

CollPlant Biotechnologies Ltd.

$5M

PULM

Pulmatrix, Inc.

$5M

BCAB

BioAtla, Inc.

$5M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.